✦ LIBER ✦

595 UGT1A1 polymorphisms correlate with adverse side effects and clinical response in metastatic colorectal cancer patients treated with irinotecan

✍ Scribed by E. Marcuello; A. Menoyo; E. Del Rio; M. Gomez-Pardo; M. Balcells; M. Baiget

Book ID: 118620768
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 171 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90627-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UGT1A1 gene variations and irinotecan tr

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

✍ Marcuello, E; Altés, A; Menoyo, A; del Rio, E; Gómez-Pardo, M; Baiget, M 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

UGT1A1*28 genotype and irinotecan dosage

UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study

✍ Kweekel, D M; Gelderblom, H; Van der Straaten, T; Antonini, N F; Punt, C J A; Gu 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

The Role of UGT1A1*28 Polymorphism in th

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

✍ Toffoli, G. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 104 KB

1317 The comprehensive analysis of UGT1A

1317 The comprehensive analysis of UGT1A genetic polymorphisms in patients with metastatic gastrointestinal cancer treated with irinotecan chemotherapy

✍ T. Tsujinaka; T. Satoh; T. Ura; Y. Sasaki; K. Yamazaki; M. Munakata; Y. Yamada; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

710: Clinical implication of UGT1A1 prom

710: Clinical implication of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab combined with FOLFIRI in the first-line setting

✍ Wang, J.; Lu, C.Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Predictive Role of the UGT1A1, UGT1A7, a

Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

✍ Cecchin, E.; Innocenti, F.; D'Andrea, M.; Corona, G.; De Mattia, E.; Biason, P.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 134 KB